Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.healun.2021.06.009 http://scihub22266oqcxt.onion/10.1016/j.healun.2021.06.009 34253455!8260058!34253455     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34253455&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Heart+Lung+Transplant 2021 ; 40 (9): 897-899 Nephropedia Template TP {{tp|p=34253455|t=2021. COVID-19 diagnosis and testing in pediatric heart transplant recipients |pdf=|usr=}}{{34253455}} gab.com Text COVID-19 diagnosis and testing in pediatric heart transplant recipients JO: J Heart Lung Transplant http://www.kidney.de/pget.php?&tw=1&pmid=34253455 #FOAvip Pediatric heart transplant recipients have been expected to be at higher risk of adverse events from developing COVID-19 infection. COVID-19 RNA PCR and antibody testing has been performed in our cohort of patients since March 15, 2020 and outcomes were reviewed. COVID-19 infection in our population of pediatric heart transplant recipients is common (21%), despite recommendations to avoid contact with others. Asymptomatic COVID-19 infection is common as well (55%). Despite the frequency of infection, COVID-19 is well tolerated in this population (5% admission from home; 0% mortality). A suppressed immune system does not significantly inhibit an antibody response in pediatric heart transplant recipients (>70% antibody seroconversion) and appears to persist, similar to those without transplantation (>90 days). Routine testing for COVID-19 via PCR and antibody testing enhances the ability to detect COVID-19 infection in asymptomatic patients and may help reduce unintended transmission to more susceptible individuals. Twit Text FOAVip COVID-19 diagnosis and testing in pediatric heart transplant recipients ????J Heart Lung Transplant http://www.kidney.de/pget.php?&tw=1&pmid=34253455 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34253455 #FOAvip English Wikipedia <ref>{{Cite pmid|34253455}}</ref> COVID-19 diagnosis and testing in pediatric heart transplant recipients #MMPMID34253455 Bock MJ; Kuhn MA; Chinnock RE J Heart Lung Transplant 2021[Sep]; 40 (9): 897-899 PMID34253455show ga Pediatric heart transplant recipients have been expected to be at higher risk of adverse events from developing COVID-19 infection. COVID-19 RNA PCR and antibody testing has been performed in our cohort of patients since March 15, 2020 and outcomes were reviewed. COVID-19 infection in our population of pediatric heart transplant recipients is common (21%), despite recommendations to avoid contact with others. Asymptomatic COVID-19 infection is common as well (55%). Despite the frequency of infection, COVID-19 is well tolerated in this population (5% admission from home; 0% mortality). A suppressed immune system does not significantly inhibit an antibody response in pediatric heart transplant recipients (>70% antibody seroconversion) and appears to persist, similar to those without transplantation (>90 days). Routine testing for COVID-19 via PCR and antibody testing enhances the ability to detect COVID-19 infection in asymptomatic patients and may help reduce unintended transmission to more susceptible individuals. |*COVID-19 Nucleic Acid Testing[MESH] |*COVID-19 Serological Testing[MESH] |*Heart Transplantation[MESH] |Adolescent[MESH] |COVID-19/*diagnosis/*epidemiology[MESH] |Child[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Predictive Value of Tests[MESH]COVID-19 diagnosis and testing in pediatric heart transplant recipient(epmc).pdf DeepDyve Pubget Overpricing